메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Chia-Ling Yu (Department of Pharmacy Chang-Gung Memorial Hospital) Fu-Chi Yang (Department of Neurology Tri-Service General Hospital National Defense Medical Center) Szu-Nian Yang (Department of Psychiatry Beitou Branch Tri-Service General Hospital National Defense Medical Center) Ping-Tao Tseng (WinShine Clinics in Specialty of Psychiatry) Brendon Stubbs (Physiotherapy Department South London and Maudsley NHS Foundation Trust) Ta-Chuan Yeh (Department of Psychiatry Tri-Service General Hospital National Defense Medical Center) Chih-Wei Hsu (Department of Psychiatry Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College o) Dian-Jeng Li (Department of Addiction Science Kaohsiung Municipal Kai-Syuan Psychiatric Hospital) Chih-Sung Liang (Graduate Institute of Medical Sciences National Defense Medical Center)
저널정보
대한신경정신의학회 PSYCHIATRY INVESTIGATION PSYCHIATRY INVESTIGATION 제18권 제10호
발행연도
2021.10
수록면
958 - 967 (10page)
DOI
10.30773/pi.2021.0209

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective To systematically examine the effectiveness and tolerability of psilocybin for treating end-of-life anxiety symptoms.Methods The Medline, Embase, CENTRAL, and PsycINFO databases were searched up to November 25, 2020. We enrolled clinical trials investigating psilocybin for treating end-of-life anxiety symptoms. Meta-analysis was conducted using random-effects model.Results Overall, five studies were included, revealing that psilocybin was superior to the placebo in treating state anxiety at 1 day (Hedges’ g, -0.70; 95% confidence interval, -1.01 to -0.39) and 2 weeks (-1.03; -1.47 to -0.60) after treatment. Psilocybin was more effective than placebo in treating trait anxiety at 1 day (-0.71; -1.15 to -0.26), 2 weeks (-1.08; -1.80 to -0.36), and 6 months (-0.84; -1.37 to -0.30) after treatment. Psilocybin was associated with transient elevation in systolic (19.00; 13.58?24.41 mm Hg) and diastolic (8.66; 5.18?12.15 mm Hg) blood pressure compared with placebo. The differences between psilocybin and placebo groups with regard to allcause discontinuation, serious adverse events, and heart rates were nonsignificant.Conclusion Psilocybin-assisted therapy could ameliorate end-of-life anxiety symptoms without serious adverse events. Because of the small sample sizes of the included studies and high heterogeneity on long-term outcomes, future randomized controlled trials with large sample sizes are needed.

목차

등록된 정보가 없습니다.

참고문헌 (45)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0